QC Associate at Arcellx

Redwood City, California, United States

Apply Now

Not SpecifiedCompensation

Junior (1 to 2 years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, Cell TherapyIndustries

Requirements

BS or MS in Biological Sciences, Immunology, or a related field
2+ years in pharmaceutical or biotechnology industry, including cell therapy/CAR-T experience
Hands-on experience with molecular assays and flow cytometry
Experience in cell culture and performing CAR-T functional assays
Familiarity with GMP-compliant lab practices and QC data tracking
Excellent written and oral communication skills

Responsibilities

Execute GMP-compliant testing of cell therapy products and in-process samples, with a focus on molecular assays (ddPCR, qPCR), flow cytometry, and functional assays for CAR-T cells
Perform cell culture and expansion of engineered T cells, maintaining aseptic technique and quality standards
Contribute to drafting and updating SOPs, forms, and logbooks governing lab operations, equipment maintenance, and assay procedures
Coordinate preventive maintenance, calibration, and troubleshooting of lab equipment and instruments in collaboration with internal resources and external partners
Manage inventory of cell culture reagents, molecular assay supplies, and lab materials
Support GMP investigations, including out-of-specification results, assay deviations, invalid assays, change controls, and CAPAs, with a focus on molecular and functional testing
Assist in tracking, trending, and reporting QC data for molecular assays, cell culture, and CAR-T functional studies

Skills

GMP

ddPCR

qPCR

flow cytometry

CAR-T

cell culture

aseptic technique

SOP

lab equipment maintenance

calibration

troubleshooting

Arcellx

Develops immunotherapies for cell therapy

About Arcellx

Arcellx develops immunotherapies aimed at improving cell therapy for serious diseases. Their products focus on advanced techniques that enhance the effectiveness of treatments. The company collaborates with healthcare providers and research institutions to bring these therapies to patients. Unlike many competitors, Arcellx emphasizes proprietary products and partnerships to drive their research and development efforts. The goal is to meet unmet medical needs by providing safe and effective treatment options through their innovative approach to cell therapy.

Gaithersburg, MarylandHeadquarters

2014Year Founded

$194.5MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

51-200Employees

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Unlimited Paid Time Off

Flexible Work Hours

401(k) Company Match

Fully-Paid Parental Leave

Tuition Reimbursement

Relocation Assistance

Risks

Competition from established CAR-T therapies like Abecma and Carvykti could limit market share.

Dependency on Gilead's Kite partnership poses risks if partnership dynamics change.

Phase 3 iMMagine-3 trial delays or failures could impact anito-cel's market timeline.

Differentiation

Arcellx's CART-ddBCMA has FDA Fast Track and Orphan Drug designations.

The novel D-Domain binder in anito-cel enhances antigen binding and cell killing.

ARC-SparX offers dosable and controllable CAR-T therapy options.

Upsides

Growing investment in personalized medicine aligns with Arcellx's tailored immunotherapies.

Advancements in gene editing like CRISPR enhance precision in engineered cell therapies.

Outpatient CAR-T administration could reduce costs and increase accessibility for Arcellx.

Land your dream remote job 3x faster with AI

Try Jobo Free